About the Journal
Mediterranean Journal of Pharmacy and Pharmaceutical Sciences publishes papers on a broad range of drug research pharmacy practice to those working on the drugs and clinical areas. It is a peer-reviewed and open-access journal that allows readers and authors to read and download published papers free of charge. It is committed to publishing high-quality articles in the field of pharmacy. The journal accepts manuscripts from all countries conducted in all branches of pharmacy practice and pharmaceutical sciences. Research with clear pharmaceutical implications will also be considered. Review articles of current interest and high standards are welcomed for consideration. All submissions are considered on condition that their contents have not appeared elsewhere. The journal is published online and printed quarterly on March 31, June 30, September 30, and December 31; for every year.
Mediterranean Journal of Pharmacy and Pharmaceutical Sciences conforms to standard Publication Ethics.
Aims & scope
Mediterranean Journal of Pharmacy and Pharmaceutical Sciences is open access fully refereed international journal. The journal is based on independent and unbiased double-blinded peer-reviewed principles. Only unpublished papers that are not under review for publication elsewhere can be submitted.
Mediterranean Journal of Pharmacy and Pharmaceutical Sciences does not accept multiple and duplicate submissions. The authors are responsible for the scientific content of the material to be published. The journal reserves the right to request any research materials on which the paper is based.
Mediterranean Journal of Pharmacy and Pharmaceutical Sciences publishes interesting original research conducted in all fields of Pharmaceutical sciences, related clinical subjects, short communications, reviews, editorials, comments, and letter to the Editor including reports on publication and research ethics. The journal encourages and enables academicians, researchers, specialists, and pharmacists of all countries to publish their valuable research in all branches of pharmacy and pharmaceutical sciences.
Open Access Policy
Mediterranean Journal of Pharmacy and Pharmaceutical Sciences (Mediterr J Pharm Pharm Sci, ISSN: 2789-1895e & 2958-3101p) is an open-access journal. The open-access means all content is freely available without any fees or charges to the user or the user’s organization. They are permitted to read, download, distribute, or recreate information in any medium or format like a print, or copy, or can use it for any lawful purpose. They are free to search, remix, transform, and build upon the material, or link to the full texts of the articles, without asking prior permission from the publisher or the author according to BOAI's definition of open access.
CC Licenses: All the contents of this journal are licensed under a Creative Commons Attribution 4.0 International License.
Copyright & Licensing
Mediterranean Journal of Pharmacy and Pharmaceutical Sciences (Mediterr J Pharm Pharm Sci, ISSN: 2789-1895 online & 2958-3101 print) applies the license of CC BY (Creative Commons Attribution 4.0 International license). This license allows authors to keep ownership of the copyright of their papers. But this license permits any user to download, print out, extract, reuse, archive, and distribute the article, so long as appropriate credit is given to the authors and the source of the work. The license ensures that the article will be available as widely as possible and that the article can be included in any scientific archive.
Journal fee
Publication Fee: The publication fee will always be free of charge.
Processing Fee: The Mediterranean Journal of Pharmacy and Pharmaceutical Sciences charges an Article Processing Charge (APC) on editorially accepted manuscripts to cover the cost of further process for internal authors (Libya, fifty dollars, $50), with no charge for external authors (out of Libya). After you submit your manuscript and are editorially accepted by the editorial board, it is necessary to pay the APC before it can proceed further for peer review.
